Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
暂无分享,去创建一个
F. Clatot | F. Di Fioré | A. Perdrix | C. Guillemet | D. Sefrioui | V. Allouchery | L. Beaussire | N. Sarafan‐Vasseur | L. Augusto